The lymphedema treatment market is estimated to be valued at US$ 1.98 Bn in 2023 and is expected to exhibit a CAGR of 9.9% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
The lymphedema treatment market consists of products used for both diagnosis and treatment of lymphedema. The main products in this market include compression garments, bandages & wraps, pneumatic pumps and multilayer bandaging. These products aid in reducing swelling, promoting healing and preventing new infections. Lymphedema can develop as a result of cancer treatment like surgery, radiation or both which damages the lymphatic system’s ability to drain lymph fluid from arms, legs, neck or torso.

Market Dynamics:
The growth of lymphedema treatment market is majorly driven by rising prevalence of lymphedema worldwide. Lymphedema commonly occurs as a long-term side effect of breast cancer treatment. According to WHO, breast cancer is the most common cancer in women with over 2 million new cases registered in 2018. Rising breast cancer incidence is expected to significantly drive the lymphedema treatment market growth. Additionally, favorable reimbursement policies for lymphedema treatment products along with new product launches are further fueling the market growth. For instance, addition of dynamic pneumatic compression therapy and advanced compression garments with gradient compression features have improved the treatment outcomes for lymphedema patients. Furthermore, growing awareness about lymphedema diagnosis and management among patients and physicians is expected to offer lucrative growth opportunities for players in this market over the forecast period.

Read More - https://makuv.com/physiotherapy-is-the-fastest-growing-segment-fueling-the-growth-of-lymphedema-treatment-market